Skip to main content
Clinical Trials/CTRI/2014/09/005064
CTRI/2014/09/005064Active, not recruiting未知

Assessment of Prevalence of Depression among Cancer Patients Undergoing Chemotherapy Using BDI and PHQ-9 Questionnaire.

JAMIA HAMDARD0 sites20 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Active, not recruiting
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Patients must have histologically or cytologically confirmed cancer
  • Patients receiving chemotherapy for the treatment of cancer
  • Both male and female patients
  • Patients capable of giving informed consent
  • Patients willing to participate in the study

Exclusion Criteria

  • History of major depression
  • Meet the DSM-IV criteria for a major depressive episode.
  • Meet criteria for treatment resistant depression defined by failure to, respond to, or intolerance of, at least 2 treatments of antidepressants
  • Active suicidal ideation
  • History of any major operation in past 6 months excluding surgeries related to cancer treatment
  • History of any significant cognitive impairment in past
  • On any psychotropic medications
  • Presence of any other concurrent illness(Parkinson disorder; Vascular disorders like Hypertension, Stroke; Endocrine disorders like Type II Diabetes Mellitus, Hypothyroidism; AIDS/HIV and rheumatoid arthritis)
  • Using any concurrent medication like clonidine, methyldopa, isotretinoin, phenobarbital, levetiracetam, phenytoin, triptans and hormonal agents (corticosteroids, oral contraceptives, GnRH agonists and tamoxifen) or whose side effect is depression
  • Suffered anxiety episodes in past
  • History of Schizophrenia
  • Alcoholics
  • Habit of any substance of abuse
  • History of significant dementia or intellectual disability
  • Incompetent for interview
  • Psychological, familial, sociological, or geographical conditions that do not permit treatment or medical follow-up and / or prohibit compliance with the study protocol

Investigators

Similar Trials